Zimbabwe has rejected a major US health deal worth 367 million US dollars (£272m) over five years due to the United States' insistence on sensitive information.
This move came to light after a government memo dated December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the agreement was "skewed".
A government spokesperson has since clarified that the United States was requesting health data for research and commercial purposes while refused to guarantee the benefits from future medical innovations.
"We will now turn to the difficult and regrettable task of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had donated over $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has urged more dialogue to reach a deal suitable to both sides so the country's vital HIV treatment initiative can continue.
Broader Context
This development follows a similar situation in neighbouring Kenya, where a high court halted a related deal with the US following concerns were filed about the safety of Kenyans' medical information.
After resuming the presidency last year, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
The agency had overseen aid for the US government, but Trump claimed its spending was "wasteful" and his government was pursuing direct bilateral deals to enhance transparency and accountability.
Based on statements, 16 nations in Africa have so far agreed to these new agreements, representing more than $18.3bn of fresh investment.
Details of the Declined Agreement
The money for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this cooperation could have provided immense benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy via US-supported initiatives," Tremont said.
However, official spokesman Nick Mangwana maintained the arrangement was "unfair".
"Our nation was requested to provide its genetic material and health information for a long time, with no equivalent promise of access to any medical innovations – like new medicines or tests – that could result from that provided information," he stated.
"Put simply, our nation would provide the raw materials for medical research with no certainty that the end products would be accessible to our citizens should a future disease outbreak emerge."
Sovereignty and International Frameworks
Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were disrupting structures previously set up through the global health agency.
Mangwana cited its Pandemic Benefit-Sharing scheme designed to manage future pandemics.
"This system is intended to guarantee that when a country contributes its information, the benefits – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the resources to create them."
The government's concerns regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We are open to continued dialogue with our US partners on how subsequent co-operation might be structured in a manner that honours the independence and dignity of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but recommended that talks must proceed considering much of the country's Aids initiatives depended on external financing.
"If specific concerns arise, such as those relating to information security or implementation frameworks, these can frequently be resolved through detailed discussion and negotiated safeguards," it commented.
This impasse emphasises the ongoing challenges between receiving much-needed international aid and safeguarding a country's data in an ever more data-driven world.